Results 171 to 180 of about 213,305 (310)
Effect of Austerity Measures on Infant Mortality: Evidence From Greece
ABSTRACT Governments frequently adopt austerity policies when facing economic crises, yet their long‐term consequences for population health remain incompletely understood. This paper examines the impact of large‐scale fiscal austerity on infant mortality by exploiting the Troika‐led economic adjustment program implemented in Greece beginning in 2010 ...
Robert J. Kolesar, Rok Spruk
wiley +1 more source
Unlocking potential: Development finance reforms needed to support localized health product manufacturing. [PDF]
Lynch S +4 more
europepmc +1 more source
ABSTRACT Background The expanding use of systemic therapies for recurrent and metastatic head and neck cancer has raised major concerns regarding affordability and equitable access, particularly across countries with differing income levels and health financing structures.
Arjun Gurmeet Singh +9 more
wiley +1 more source
The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies. [PDF]
Atilgan E +4 more
europepmc +1 more source
Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies. [PDF]
Simoens S +14 more
europepmc +1 more source
ABSTRACT The unquenched thirst for emigration in Nigeria‐ and the increasing cost of migrating to the West‐has been established in the literature. Professionals, such as healthcare workers (HCWs), are poorly paid in Nigeria, making many seek better employment abroad.
Tunde A. Alabi +3 more
wiley +1 more source
Global mechanisms to improve affordability of high-priced medicines: the role of the WHO model lists of essential medicines. [PDF]
Jenei K.
europepmc +1 more source
What's New? Estimating the risk of developing brain metastases may enable earlier diagnosis and treatment, potentially reducing morbidity and mortality. Using the prospective CRISP lung cancer registry, the authors developed and validated a point‐based classifier for the risk of developing first brain metastases in patients with advanced or metastatic ...
Fabian Acker +19 more
wiley +1 more source
Uncertainty persists over whether the benefits of prostate‐specific antigen (PSA) screening outweigh harms from overdiagnosis, a key barrier to population‐wide adoption. Here, English male mortality rates were analyzed alongside long‐term data from the UK Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) to estimate age‐specific ...
Adam R. Brentnall +5 more
wiley +1 more source

